China STD diagnostics market is growing at a CAGR of around 9.5% during the forecast period. China, which is one of the largest developing countries across the globe, has been suffering from the wide-spread of STDs for a long time. Among all of the STDs in China, three are listed as the notifiable infectious diseases, i.e., Gonorrhoea, Syphilis, and HIV/AIDS, which demand more attention, which is influencing the growth of the China STD diagnostics market. Overall, the Yangtze River Delta region, the southwestern border area, and some other border regions are the places demanding more attention.
Free Sample Copy @ https://www.omrglobal.com/request-sample/china-sexually-transmitted-disease-market
The rate of STD in China has recently increased drastically over the years. In China, the high-risk community consists of migrants, workers, prostitutes and their clients, drug users, and homosexuals. Most of the STDs can be treated if it the disease is quickly diagnosed. In China, there are local specialized STD hospitals, including the Shanghai Skin Disease and other large and local hospitals such as Huashan hospital. These hospitals provide STD diagnosis tests across the region. Further, in 2016, the Chinese Centre for Disease Control and Prevention (CCDC) reported 96,000 new HIV cases in the first nine months. China has increased HIV testing efforts and changed its approach depending on the type of group or population being targeted.
A Full Report of China Sexually Transmitted Diseases (STD) Diagnostics Market is Available at:
https://www.omrglobal.com/industry-reports/china-sexually-transmitted-disease-market
In addition, Abbott Laboratories, Inc., AbbVie Inc., Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd. among others are the key manufactures that encourages the China STD market growth. These market players are considerably contributing to the China STD diagnostic market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the China STD diagnostics market.
China Sexually Transmitted Diseases (STD) Diagnostics Market – Segmentation
by Disease Type
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus (HSV)
Human Papilloma Virus (HPV)
Human Immunodeficiency Virus (HIV)
Others
by Product
Laboratory Testing Devices
Point-of-Care (POC) Testing Devices
by End-user
Hospitals and Clinics
Diagnostic Centers
Homecare
Company Profiles
Abbott Laboratories, Inc.
AbbVie Inc.
Becton, Dickinson and Co.
Biocartis NV
Bio-Rad Laboratories, Inc.
Danaher Corp.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Thermo Fisher Scientific, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-sexually-transmitted-disease-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)
